Literature DB >> 17693825

Abdominal insufflation for control of bleeding after severe splenic injury.

George C Velmahos1, Konstantinos Spaniolas, Michael Duggan, Hasan B Alam, Malek Tabbara, Marc de Moya, Kirby Vosburgh.   

Abstract

BACKGROUND: To date, there is no rapid method to control intracavitary bleeding without an operation. Over 70% of trauma deaths from uncontrollable internal bleeding occur early after injury before an operation is feasible. Abdominal insufflation (AI) by carbon dioxide has been shown to reduce the rate of bleeding after intra-abdominal injury in pigs. The concept was proven in highly lethal models of severe vascular and liver injuries. Similar injuries in humans would result in immediate exsanguination and low likelihood for any intervention. We hypothesized that AI would similarly reduce bleeding in a model of moderate but persistent bleeding from a splenic injury. This model represents a clinically relevant scenario of continuous bleeding, which does not kill the patient immediately but may ultimately result in death if not managed early.
METHODS: A new model of splenic injury was applied on 19 pigs, randomized to standard resuscitation (SR, N = 10) or standard resuscitation with AI to 20 cm H2O (SRAI, N = 9). For 30 minutes, the pigs were bled and the hemodynamics recorded. At 30 minutes, the abdomen was opened and free blood was collected and measured. Outcomes were blood loss, mean arterial pressure, hemoglobin, lactate levels, and arterial blood gases at the end of the experiment.
RESULTS: All pigs survived to the end of the experiment. Blood loss was lower (1,114 +/- 486 mL vs. 666 +/- 323 mL, p = 0.03) and final mean arterial pressure higher (64 +/- 12 mm Hg vs. 54 +/- 8 mm Hg, p = 0.04) in SRAI when compared with those in SR animals. Heart rate, arterial blood gases, oxygen saturation, hemoglobin, and lactate levels were similar in the two groups, except there was a more acidotic pH among SRAI animals (7.27 +/- 0.06 vs. 7.47 +/- 0.21, p = 0.02).
CONCLUSIONS: AI is a novel method to control intra-abdominal bleeding temporarily. With proper portable instruments and first-responder training, this is a technique that can potentially be used in the field to save lives from intra-abdominal exsanguination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17693825     DOI: 10.1097/TA.0b013e3180d0a6ea

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  6 in total

Review 1.  Intravenous hemostats: challenges in translation to patients.

Authors:  Margaret Lashof-Sullivan; Andrew Shoffstall; Erin Lavik
Journal:  Nanoscale       Date:  2013-10-02       Impact factor: 7.790

2.  Carbon dioxide: the cause of devastating stroke without hemodynamic compromise during laparoscopic nephrectomy with injury of the inferior vena cava: A case report.

Authors:  Youxiu Yao; Mao Xu
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

3.  Blood oxygenation during hyperpressure intraperitoneal fluid administration in a rabbit model of severe liver injury: Evaluation of a novel concept for control of pre-hospital liver bleeding.

Authors:  Siavash Ahmadi-Noorbakhsh; Saeed Azizi; Bahram Dalir-Naghadeh; Masoud Maham
Journal:  Vet Res Forum       Date:  2012       Impact factor: 1.054

4.  Hemorrhage control of liver injury by short electrical pulses.

Authors:  Yossi Mandel; Guy Malki; Eid Adawi; Elon Glassberg; Arnon Afek; Michael Zagetzki; Ofer Barnea
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

5.  Blood loss during laparoscopic radical prostatectomy - is it significant or not?

Authors:  Sławomir Poletajew; Artur A Antoniewicz
Journal:  Cent European J Urol       Date:  2012-03-19

Review 6.  Prehospital control of life-threatening truncal and junctional haemorrhage is the ultimate challenge in optimizing trauma care; a review of treatment options and their applicability in the civilian trauma setting.

Authors:  S E van Oostendorp; E C T H Tan; L M G Geeraedts
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-09-13       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.